삼성서울병원

Ko En

유방외과분과 유종한 교수

진료분야
유방암, 유방암수술, 유방악성질환
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2016.02 서울대학교 대학원 의학 박사 졸업
2008.08 서울대학교 대학원 의학 석사 졸업
2000.02 서울대학교 의학과 졸업

경력

경력
2022.03 ~현재 삼성서울병원 유방외과 교수
2022.03 ~현재 성균관대학교 의과대학 외과학교실 교수
2021.12 ~현재 삼성서울병원 커뮤니케이션 실차장
2017.0301 ~현재 삼성서울병원 유방암센터 간사
2018.0301 ~ 2022.02 삼성서울병원 외과 전임대우 부교수
2015.10 ~ 2018.02 삼성서울병원 외과 진료부교수
2015.03 ~ 2015.09 서울아산병원 외과 임상부교수
2010.03 ~ 2015.02 서울아산병원 외과 임상조교수
2009.03 ~ 2010.02 서울대학교병원 외과 진료교수
2008.05 ~ 2009.02 서울대학교병원 외과 전임의
2001.03 ~ 2005.02 서울대학교병원 외과 레지던트 과정 수료
2000.03 ~ 2001.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2021.05 ~ 현재 한국유방암학회 임상시험위원회 위원장
2020.12 ~ 2022.11 대한림프부종학회 재무위원회 위원장
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01559-5 Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.673 Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • THER ADV MED ONCOL 2023 10.1177/17588359231189421 Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • ECLINICALMEDICINE 2023 10.1016/j.eclinm.2023.102085 The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus Kaidar-Person, O; Pfob, A; Gentilini, OD; Borisch, B; Bosch, A; Cardoso, MJ; Curigliano, G; De Boniface, J; Denkert, C; Hauser, N; Heil, J; Knauer, M; Kuhn, T; Lee, HB; Loibl, S; Mannhart, M; Meattini, I; Montagna, G; Pinker, K; Poulakaki, F; Rubio, IT; Sager, P; Steyerova, P; Tausch, C; Tramm, T; Peeters, MJV; Wyld, L; Yu, JH; Weber, WP; Poortmans, P; Dubsky, P
    View PubMed
  • ONCOLOGIST 2023 10.1093/oncolo/oyad156 A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer Lee, HB; Lee, KH; Song, SH; Kim, K; Kim, HK; Moon, HG; Han, WS; Lee, DW; Im, SA; Jang, BS; Kim, YB; Yu, JH; Kim, JH; Park, YH; Shin, KH; Chang, JH
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e11 Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e17 Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.104.3.137 The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • HEALTH INFORM J 2023 10.1177/14604582231156476 Feasibility and usability of a personalized mHealth app for self-management in the first year following breast cancer surgery Lim, JY; Kim, Y; Yeo, SM; Chae, BJ; Yu, JH; Hwang, JH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12389-0 Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12602-0 ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.903372 Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06500-4 Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy Cheun, JH; Lee, YJ; Lee, JH; Shin, Y; Chun, JW; Baek, SY; Kim, HK; Lee, HB; Yu, J; Chae, BJ; Han, W; Lee, JE
    View PubMed
  • CANCER GENET-NY 2022 10.1016/j.cancergen.2022.05.042 Discovery of BRCA1/BRCA2 founder variants by haplotype analysis Kwon, WK; Jang, HJ; Lee, JE; Park, YH; Ryu, JM; Yu, J; Jang, JH; Kim, JW
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • KOREAN J RADIOL 2022 10.3348/kjr.2020.1475 Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients Kwon, MR; Ko, ES; Park, MS; Jeong, WK; Hwang, NY; Kim, JH; Lee, JE; Kim, SW; Yu, JH; Han, BK; Ko, EY; Choi, JS; Park, KW
    View PubMed
  • VIRCHOWS ARCH 2022 10.1007/s00428-022-03280-0 Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06483-2 Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0260681 Privacy-preserving breast cancer recurrence prediction based on homomorphic encryption and secure two party computation Son, YH; Han, K; Lee, YS; Yu, JH; Im, YH; Shin, SY
    View PubMed
  • CANCER PREV RES 2021 10.1158/1940-6207.CAPR-20-0542 The Relationship Between Breast Density Change During Menopause and the Risk of Breast Cancer in Korean Women Kang, D; Kim, JY; Kim, JY; Mun, HS; Yoon, SJ; Lee, J; Han, G; Im, YH; Shin, SY; Lee, SK; Yu, JH; Lee, KH; Kim, M; Park, D; Choi, YH; Jeong, OS; Lee, JH; Jekal, SY; Choi, JS; Guallar, E; Chang, Y; Ryu, S; Cho, J; Kang, M
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-00278-7 From cadaveric and animal studies to the clinical reality of robotic mastectomy: a feasibility report of training program Lee, J; Park, HS; Lee, DW; Song, SY; Yu, J; Ryu, JM; Bae, SJ; Lew, DH; Kim, SI; Toesca, A
    View PubMed
  • BREAST CANCER RES TR 2021 10.1007/s10549-021-06309-1 Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e194 Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277 Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.596364 Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH
    View PubMed
  • BMC SURG 2021 10.1186/s12893-021-01129-y The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW
    View PubMed
  • CANCERS 2021 10.3390/cancers13051177 Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study Choi1, IY; Chun, S; Shin, DW; Han, K; Jeon, KH; Yu, J; Chae, BJ; Suh, M; Park, YM
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e4 Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
    View PubMed
  • EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023 Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-020-07729-w Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander? Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • JAMA SURG 2020 10.1001/jamasurg.2020.4124 Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence Lee1, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251 Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer? Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-74577-w Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients Gwark1, SC; Kim, J; Lee, CH; Kim, YH; Kim, MS; Hong, SW; Choi, MY; Jeon, BH; Kwon, NJ; Kim, KY; Kim, Y; Chang, S; Yu, JH; Park, JY; Ahn, JH; Jung, KH; Kim, SB; Lee, HJ; Gong, GY; Lee, SB; Chung, IY; Ko, BS; Kim, HJ; Lee, JW; Son, BH; Ahn, SH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9092846 Impact of Serum Lipid on Breast Cancer Recurrence Jung1, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK
    View PubMed
  • MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108 Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer Park1, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH
    View PubMed
  • NUTRIENTS 2020 10.3390/nu12092831 Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients Kim1, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041192 Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
    View PubMed
  • CANCER 2020 10.1002/cncr.32693 Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea Shin1, DW; Yu, J; Cho, J; Lee, SK; Jung, JH; Han, K; Kim, SY; Yoo, JE; Yeob, KE; Kim, YY; Park, JH; Park, JH; Kawachi, I
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.342 Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance Kim1, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH
    View PubMed
  • ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169 Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0212309 Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • ONCOL REP 2019 10.3892/or.2018.6910 TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011 A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-018-5258-9 Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea Kim1, HK; Lee, SH; Kim, YJ; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Ahn, JS; Im, YH; Yu, JH; Park, YH
    View PubMed
  • ASIAN J SURG 2019 10.1016/j.asjsur.2018.06.004 Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice Lee1, SB; Yu, JH; Park, H; Kim, HJ; Park, SH; Chae, BJ; Youn, HJ; Jung, SY; Kim, EK; Jung, YS; Son, BH
    View PubMed
  • NUTRIENTS 2019 10.3390/nu11010037 Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
    View PubMed
  • HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3 The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e54 Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003 Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e50 Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
    View PubMed
  • PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004 Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010 Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
    View PubMed
  • ONCOLOGY-BASEL 2018 10.1159/000488944 Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • HEALTH QUAL LIFE OUT 2018 10.1186/s12955-018-0965-0 Uneven recovery patterns of compromised health-related quality of life (EQ-5D-3 L) domains for breast Cancer survivors: a comparative study Yu1, J; Son, WS; Lee, SB; Chung, IY; Son, BH; Ahn, SH; Jo, MW; Lee, JW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.206 Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.222 Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.173 Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4342-7 Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.91 Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.21 Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S
    View PubMed
  • CELL PHYSIOL BIOCHEM 2018 10.1159/000487171 Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003 Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002 Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5 Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014 Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22220 Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4398-y Radiation-related heart disease after breast cancer radiation therapy in Korean women Chang1, JS; Ko, BK; Bae, JW; Yu, JH; Park, MH; Jung, Y; Jeon, YW; Kim, KH; Shin, J; Suh, CO; Kim, YB
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22193 Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers Park1, B; Hopper, JL; Win, AK; Dowty, JG; Sung, HK; Ahn, C; Kim, SW; Lee, MH; Lee, J; Lee, JW; Kang, E; Yu, JH; Kim, KS; Moon, BI; Han, W; Noh, DY; Park, SK
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.528 Education Level Is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: A Study Based on the Nationwide Korean Breast Cancer Registry Database Hwang1, KT; Noh, W; Cho, SH; Yu, J; Park, MH; Jeong, J; Lee, HJ; Kim, J; Oh, S; Kim, YA
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.3.297 Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.203.270 Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24. Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24. Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.
    View PubMed
  • Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746. Conditional disease-free survival among patients with breast cancer Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.
    View PubMed
  • Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.
    View PubMed
  • Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.
    View PubMed